Aris Garro1,2, Adam Chodobski2, Joanna Szmydynger-Chodobska2, Rongzi Shan2, Shara R Bialo1,2, Jonathan Bennett3, Kimberly Quayle4, Arleta Rewers5, Jeffrey E Schunk6, T Charles Casper6, Nathan Kuppermann7, Nicole Glaser8. 1. Departments of Pediatrics and Emergency Medicine, Rhode Island Hospital, Providence, RI, USA. 2. Warren Alpert Medical School, Brown University, Providence, RI, USA. 3. Department of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University, Wilmington, DE, USA. 4. Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA. 5. Department of Pediatrics, University of Colorado, School of Medicine, Denver, CO, USA. 6. Department of Pediatrics, University of Utah, School of Medicine, Salt Lake City, UT, USA. 7. Department of Emergency Medicine, University of California Davis, Davis, CA, USA. 8. Department of Pediatrics, University of California Davis, Davis, CA, USA.
Abstract
BACKGROUND AND OBJECTIVE: Matrix metalloproteinases (MMPs) mediate blood-brain barrier dysfunction in inflammatory disease states. Our objective was to compare circulating MMPs in children with diabetic ketoacidosis (DKA) to children with type 1 diabetes mellitus without DKA. RESEARCH DESIGN AND METHODS: This was a prospective study performed at five tertiary-care pediatric hospitals. We measured plasma MMP-2, MMP-3, and MMP-9 early during DKA (time 1; within 2 h of beginning intravenous fluids) and during therapy (time 2; median 8 h; range: 4-16 h). The primary outcome was MMP levels in 34 children with DKA vs. 23 children with type 1 diabetes without DKA. Secondary outcomes included correlations between MMPs and measures of DKA severity. RESULTS: In children with DKA compared with diabetes controls, circulating MMP-2 levels were lower (mean 77 vs. 244 ng/mL, p < 0.001), MMP-3 levels were similar (mean 5 vs. 4 ng/mL, p = 0.57), and MMP-9 levels were higher (mean 67 vs. 25 ng/mL, p = 0.002) early in DKA treatment. MMP-2 levels were correlated with pH at time 1 (r = 0.45, p = 0.018) and time 2 (r = 0.47, p = 0.015) and with initial serum bicarbonate at time 2 (r = 0.5, p = 0.008). MMP-9 levels correlated with hemoglobin A1c in DKA and diabetes controls, but remained significantly elevated in DKA after controlling for hemoglobin A1c (β = -31.3, p = 0.04). CONCLUSIONS:Circulating MMP-2 levels are lower and MMP-9 levels are higher in children during DKA compared with levels in children with diabetes without DKA. Alterations in MMP expression could mediate BBB dysfunction occurring during DKA.
RCT Entities:
BACKGROUND AND OBJECTIVE: Matrix metalloproteinases (MMPs) mediate blood-brain barrier dysfunction in inflammatory disease states. Our objective was to compare circulating MMPs in children with diabetic ketoacidosis (DKA) to children with type 1 diabetes mellitus without DKA. RESEARCH DESIGN AND METHODS: This was a prospective study performed at five tertiary-care pediatric hospitals. We measured plasma MMP-2, MMP-3, and MMP-9 early during DKA (time 1; within 2 h of beginning intravenous fluids) and during therapy (time 2; median 8 h; range: 4-16 h). The primary outcome was MMP levels in 34 children with DKA vs. 23 children with type 1 diabetes without DKA. Secondary outcomes included correlations between MMPs and measures of DKA severity. RESULTS: In children with DKA compared with diabetes controls, circulating MMP-2 levels were lower (mean 77 vs. 244 ng/mL, p < 0.001), MMP-3 levels were similar (mean 5 vs. 4 ng/mL, p = 0.57), and MMP-9 levels were higher (mean 67 vs. 25 ng/mL, p = 0.002) early in DKA treatment. MMP-2 levels were correlated with pH at time 1 (r = 0.45, p = 0.018) and time 2 (r = 0.47, p = 0.015) and with initial serum bicarbonate at time 2 (r = 0.5, p = 0.008). MMP-9 levels correlated with hemoglobin A1c in DKA and diabetes controls, but remained significantly elevated in DKA after controlling for hemoglobin A1c (β = -31.3, p = 0.04). CONCLUSIONS: Circulating MMP-2 levels are lower and MMP-9 levels are higher in children during DKA compared with levels in children with diabetes without DKA. Alterations in MMP expression could mediate BBB dysfunction occurring during DKA.
Authors: Mira Lischper; Simon Beuck; Gokulan Thanabalasundaram; Christian Pieper; Hans-Joachim Galla Journal: Brain Res Date: 2010-03-01 Impact factor: 3.252
Authors: N Glaser; P Barnett; I McCaslin; D Nelson; J Trainor; J Louie; F Kaufman; K Quayle; M Roback; R Malley; N Kuppermann Journal: N Engl J Med Date: 2001-01-25 Impact factor: 91.245
Authors: Taylor E Close; Gediminas Cepinskas; Tatsushi Omatsu; Keeley L Rose; Kelly Summers; Eric K Patterson; Douglas D Fraser Journal: Microcirculation Date: 2013-08 Impact factor: 2.628
Authors: Carine Savarin; Stephen A Stohlman; Anna M Rietsch; Niranjan Butchi; Richard M Ransohoff; Cornelia C Bergmann Journal: Glia Date: 2011-07-28 Impact factor: 7.452
Authors: William H Hoffman; Cornelia D Cudrici; Dallas Boodhoo; Alexandru Tatomir; Violeta Rus; Horea Rus Journal: Exp Mol Pathol Date: 2019-04-13 Impact factor: 3.362
Authors: Nicole Glaser; Steven Chu; Justin Weiner; Linnea Zdepski; Heike Wulff; Daniel Tancredi; Martha E ODonnell Journal: BMJ Open Diabetes Res Care Date: 2022-05
Authors: Simona Ghetti; Nathan Kuppermann; Arleta Rewers; Sage R Myers; Jeff E Schunk; Michael J Stoner; Aris Garro; Kimberly S Quayle; Kathleen M Brown; Jennifer L Trainor; Leah Tzimenatos; Andrew D DePiero; Julie K McManemy; Lise E Nigrovic; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; Nicole S Glaser Journal: Diabetes Care Date: 2020-09-22 Impact factor: 19.112
Authors: Nathan Kuppermann; Simona Ghetti; Jeff E Schunk; Michael J Stoner; Arleta Rewers; Julie K McManemy; Sage R Myers; Lise E Nigrovic; Aris Garro; Kathleen M Brown; Kimberly S Quayle; Jennifer L Trainor; Leah Tzimenatos; Jonathan E Bennett; Andrew D DePiero; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; J Michael Dean; Nicole S Glaser Journal: N Engl J Med Date: 2018-06-14 Impact factor: 91.245
Authors: Sage R Myers; Nicole S Glaser; Jennifer L Trainor; Lise E Nigrovic; Aris Garro; Leah Tzimenatos; Kimberly S Quayle; Maria Y Kwok; Arleta Rewers; Michael J Stoner; Jeff E Schunk; Julie K McManemy; Kathleen M Brown; Andrew D DePiero; Cody S Olsen; T Charles Casper; Simona Ghetti; Nathan Kuppermann Journal: JAMA Netw Open Date: 2020-12-01